HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Brugière, O. Articles by Fournier, M. Search for Related Content PubMed PubMed Citation Articles by Brugière, O. Articles by Fournier, M.

Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome

Depts of ¹ Pneumology, ² Thoracic Surgery, and ³ Pathology, Beaujon Hospital, Clichy, France

CORRESPONDENCE: O. Brugière, Service de Pneumologie et Réanimation Respiratoire, Hôpital Beaujon, 100 bd du Gén. Leclerc, 92000 Clichy, France. Fax: 33 142708719. E-mail: olivier.brugiere@bjn.ap-hop-paris.fr

Keywords: Bronchiolitis obliterans syndrome, exhaled nitric oxide, lung transplantation

Received: May 12, 2004
Accepted December 10, 2004

Bronchiolitis obliterans syndrome (BOS) remains the leading cause of morbidity/mortality following lung transplantation. In recipients with BOS, markers predicting the decline in lung function are needed. The aim of this longitudinal study was to determine whether exhaled nitric oxide fraction (F_eNO) measurements provide useful information for discriminating patients with unstable BOS from those with stable BOS.

During a 14-month period, 145 F_eNO measurements were performed in 50 lung transplant recipients. Among them, 16 recipients with BOS (32 F_eNO measurements) were analysed. For each F_eNO measurement, the patients were classified into three groups according to the decline in forced expiratory volume in one second (FEV₁) within the following 6 months: 1) stable BOS free; 2) stable BOS (decline in FEV₁ of <5%); and 3) unstable BOS (decline in FEV₁ of 15%).

The mean F_eNO in patients with unstable BOS was significantly increased compared with that in stable BOS-free patients (18.4±5.7 versus 9.7±3.7 ppb) and that in patients with stable BOS (18.4±5.7 versus 9.7±3.3 ppb).

The present findings suggest that, in patients with bronchiolitis obliterans syndrome, a raised exhaled nitric oxide fraction may predict the development of worrisome functional impairment during long-term follow-up.

This article has been cited by other articles:

				A. Van Muylem, C. Knoop, and M. Estenne Early Detection of Chronic Pulmonary Allograft Dysfunction by Exhaled Biomarkers Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 731 - 736. [Abstract] [Full Text] [PDF]

				D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax, September 1, 2006; 61(9): 817 - 827. [Abstract] [Full Text] [PDF]